ETS-positive prostate cancers

0:40:24

Clinical relevance of genomics in definitive management of prostate cancer

0:36:44

Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs, etc.

1:01:51

Elucidating tumor heterogeneity in prostate cancer by combined IHC & novel RNA ISH

0:22:12

Prostate Cancer 2021 Screening and Prevention

0:23:20

The Microbiome as a Mediator of Prostate Carcinogenesis

0:58:16

Prostate Cancer: Active surveillance as a treatment option?

0:17:24

Epidemiology & Genomics of Prostate Cancer in Asian Men

0:20:42

Screening for Prostate Cancer

0:28:19

Targeting AR in Castration Resistant Prostate Cancer

1:02:32

Stanford Radiology: CEDSS (Fall) 2020, Boutros: Origins and Detection of Lethal Prostate Cancer

0:25:27

E01.1 Genome sequencing in prostate cancer

1:00:42

10/06/2023: Trends in Screening, Diagnosis and Treatment of Prostate Cancer

0:12:02

AR Resistance Mechanisms Focusing on Variants and Testing

1:16:40

MS Urology Online Presentations: Metastatic Hormone Refractory Prostate Cancer

0:49:38

Expert Angle: Predicting the Future with Dr. John Lewis

0:58:50

1.21.22 Resident didactic: Advanced prostate cancer - Principles and AUA Guideline

1:35:34

TRACO 2015: Prostate Cancer - Radiation Oncology

0:24:56

Genetic Testing in Advanced Prostate Cancer

0:35:29

Genomic Testing for Clinical Decision Making in Patients with Advanced Prostate Cancer - M. A. Rubin

0:21:52

AR V7 Predicts Response in CRPC

1:04:41

Francesca Khani MD - Virtual Pathology Grand Rounds - April 2, 2020

0:59:45

JC : Genomic alterations in Prostate cancer

0:44:18

Update in Prostate Cancer 2022

1:00:26

Diagnostic Biomarkers of Prostate Cancer in 2023 and Beyond